{"ticker": {"uuid": "16b408c9-40d3-4693-b860-7aa98f1d0c45", "symbol": "BVS", "name": "Bioventus Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Hillsdale Investment Management Inc. Raises Stake in Bioventus Inc. $BVS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPM1FNSWZyZkZxV2dsSzFqWGtXc3NOdHFZR21lLWhjbzBiRnI3UnlnU3VhcTRFX1JqSldFbFlWRTl0c1VxcjI1c1NEN3FWT0JzdHQ4RlZreF9XR0hJRlJlNDU4RXRFZ0R1RHBDeU55RU9Qeno1Q0Z0RGhQZDg5cWhCQjJLaG1jY1VYRU0xRVRjbFZuZzItNHFYQVlSb0hPYXUwOTRmT0NpUU81RW94aVVoRzd6WE5LYlNGa29SOVlpN09KbFM3d2hnelF3?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T10:35:49+00:00", "published_display": "15 Jul 2026 10:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus Inc. (NASDAQ:BVS) Given Average Rating of \"Buy\" by Brokerages", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZTZTNjh0Y2dCWlhxM1l2TmM0dlFWeVhseTQzZnM0MDRnUHhic2JoQWF0bzZGSEVJQVB5am5ZOTM5VWEtTjZrcmNMSU1vbnhpdHZFX0xXUXlfZ2p3Y0Q5ZE5JdHFJRzdaTkIyd1NaZkdRdk9zX1FtVUZkNF8tSU5neVNIZkpzTW1ic0JlR1VqaGJYbi05NWdDZEo3SERiVHg1NWVVcGlCblNiQ3JURFl2dVFTeWVOc3VhVDVv?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T08:20:57+00:00", "published_display": "15 Jul 2026 08:20", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Bioventus (BVS) Stock Looks Overvalued On Earnings Yet Backed By Broader Checks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxObWMzc1lKWkNMemFPTkVQeXBzV2RYUkxWZzZuVEVOUXhXSjFrcTB3UU11NTV4S2F5RkNBaUZEU1VGUUpQczZKYUxUMWZMeXd3akJBeUc1RFpRNXBuOXVQZVJSWnNBRk03cDJWN3VxV2xUbTA5b2x3NE9UcVV1bU41Q1V5eFRWUjdlRkNrMjhvVmc4SHphMXhiY01pSHFFQ214Tk5Z?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:14:10+00:00", "published_display": "10 Jul 2026 22:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Heads To An Investor Conference, Is It Still Below Fair Value?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T15:47:20+00:00", "published_display": "10 Jul 2026 15:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Actuals & Estimates (LSX:A2APNA)", "summary": "This article provides an overview of Bioventus, Inc. Class A (A2APNA) stock, including its current price, historical performance, and analyst forecasts. It also details financial actuals and estimates for income, balance sheet, and cash flow, along with information on earnings, r", "url": "https://www.tradingview.com/symbols/LSX-A2APNA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-07-10T03:40:15", "published_display": "10 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNRDNBTjl5WUcyaWVyTDRFMzhVeE5KOTBiTnZDb2d3Wk5WWmxuclMtUklXRXFZSktBQ0l1QjQyT1lKOGU1TTJ5WlppdzRydXQzY2o0QmN4dHpEaFNUdlJmT2hUWDBfUEJkNEZjMk1FWWVhT0RSWHd1TTVGbTE4NzNpYXBNVnZiUEhlRTB5TmE1aU1XN0pHdmF1am1B?oc=5", "source_name": "Market source", "published_at": "2026-07-08T16:00:03+00:00", "published_display": "08 Jul 2026 16:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQMzNjVHhoOFZQVEVjN1ZBWGhJR2pFREhmS0h2Tk1KeG9ONkVQdmxndmRyQ0xNZ2twQU10aGRRTlBlenE5UWEyTW5qVC00X1I3MjNUNmR1dW04QkdGaTVSRXJhOWpUZHZodG5na3RRVHRmNkJBenUxVTg4b3BzV2llWFN6Tm9hbUpIT0hzbndDa1UzUlpMNV9YTkZWTy0?oc=5", "source_name": "Market source", "published_at": "2026-07-08T13:55:01+00:00", "published_display": "08 Jul 2026 13:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A2APNA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an in-depth forecast for Bioventus, Inc. Class A (A2APNA) stock, including analyst price targets, past performance, and future earning estimates. It details current stock price, market capitalization, revenue, net income, and confirms that the company does n", "url": "https://www.tradingview.com/symbols/LSX-A2APNA/forecast/", "source_name": "TradingView", "published_at": "2026-07-08T12:40:15", "published_display": "08 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A2APNA Stock Price and Chart \u2014 LSX:A2APNA", "summary": "This article provides an overview of Bioventus, Inc. Class A (A2APNA) stock listed on the Lang & Schwarz Exchange, including key financial stats, upcoming earnings, and analyst insights. It details the company's business segments focusing on orthobiologics and musculoskeletal tre", "url": "https://www.tradingview.com/symbols/LSX-A2APNA/", "source_name": "TradingView", "published_at": "2026-07-07T18:13:46", "published_display": "07 Jul 2026 18:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zacks.com featured highlights include First Advantage, Bioventus and Ooma", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zacks-com-featured-highlights-first-081300491.html", "source_name": "Zacks", "published_at": "2026-07-07T08:13:00+00:00", "published_display": "07 Jul 2026 08:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQTW50MjNHZkd5Z19IMnJGMU1GTW1oTW5Xd19BRzB4Z2FZdzdjYVZLRzdGMkJhWWlyZlFUZFNOaU9zcEgzcXRHNGhqeS1XY3FpRFRNcHd4b0FUR09tWVRnZTBMMzhaamNYbmNJd3RJOEFybG5wNzJjSHotcmRRUkJsbDR3XzA5SjN2enFmdU9WMHlFWVU?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Debt to assets ratio of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article provides financial information for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It specifically highlights the debt to assets ratio for the company. The content also mentions the data sources and copyright information.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/debt-to-asset/", "source_name": "TradingView", "published_at": "2026-07-07T00:13:46", "published_display": "07 Jul 2026 00:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash flow from financing activities of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides financial data specifically on the cash flow from financing activities of Bioventus, Inc. Class A, traded under the symbol LS:A2APNA. The content is presented within the TradingView platform, noting the market status as closed with no trades. It highlights t", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-cash-flow/cash-f-financing-activities/", "source_name": "TradingView", "published_at": "2026-07-07T00:13:46", "published_display": "07 Jul 2026 00:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash per share of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides financial information for Bioventus, Inc. Class A (LS:A2APNA), specifically focusing on its cash per share. It appears to be a financial data page from TradingView, including general market information and links to various financial tools and community featu", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/cash-per-share/", "source_name": "TradingView", "published_at": "2026-07-06T13:39:33", "published_display": "06 Jul 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Return on equity % of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article provides a financial overview of Bioventus, Inc. Class A (A2APNA) on TradingView, specifically focusing on its Return on Equity (ROE) percentage. It indicates that the market was closed at the time of access and no trades were recorded. The content is part of a larger", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/return-on-equity/", "source_name": "TradingView", "published_at": "2026-07-06T13:09:41", "published_display": "06 Jul 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total revenue of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides financial information for Bioventus, Inc. Class A under the ticker LS:A2APNA on TradingView. It specifically highlights the \"Total revenue\" section within the financial data for the company. The content appears to be a stub or a section of a larger financial", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/total-revenue/", "source_name": "TradingView", "published_at": "2026-07-06T12:40:15", "published_display": "06 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBITDA of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article displays the EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It provides financial data for the company, indicating the period, value, and percentage change. The article focuses solely o", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/ebitda/", "source_name": "TradingView", "published_at": "2026-07-06T12:10:44", "published_display": "06 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Statistics \u2013 LS:A2APNA", "summary": "This page provides financial statistics and ratios for Bioventus, Inc. Class A (LS:A2APNA) on the Lang & Schwarz Tradecenter, including valuation, profitability, liquidity, solvency ratios, and per-share metrics. Users can access annual or quarterly data going back to 2013, thoug", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/", "source_name": "TradingView", "published_at": "2026-07-06T12:10:44", "published_display": "06 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash flow from investing activities of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article displays the cash flow from investing activities for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It appears to be a financial data page rather than a traditional article, providing access to financial information without detailed textual analysis. The content", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-cash-flow/cash-f-investing-activities/", "source_name": "TradingView", "published_at": "2026-07-06T12:10:44", "published_display": "06 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Income Statement \u2013 LS:A2APNA", "summary": "This article presents the income statement for Bioventus, Inc. Class A (A2APNA), indicating the total revenue for the last quarter was 114.33 million EUR, a 14.96% decrease from the previous quarter. The net income for Q1 2026 was 2.69 million EUR. The report includes an overview", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/", "source_name": "TradingView", "published_at": "2026-07-06T10:40:38", "published_display": "06 Jul 2026 10:40", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Equity in earnings of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides details on the equity in earnings for Bioventus, Inc. Class A (LS:A2APNA), as listed on the Lang & Schwarz Tradecenter. It indicates that the market is currently closed with no trades recorded. The page includes general market and financial data overview, wi", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/equity-in-earnings/", "source_name": "TradingView", "published_at": "2026-07-06T03:40:38", "published_display": "06 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the \"Price to sales forward\" metric for Bioventus, Inc. Class A, traded under the symbol A2APNA on the Lang & Schwarz Tradecenter. It provides an overview of the financial data available for this company through TradingView, noting that the market was close", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T01:10:32", "published_display": "06 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This page from TradingView provides financial information for Bioventus, Inc. Class A (LS:A2APNA), specifically focusing on its forward price-to-earnings ratio. The content indicates that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. It i", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T00:41:00", "published_display": "06 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Earnings and Revenue \u2013 LS:A2APNA", "summary": "Bioventus, Inc. Class A (A2APNA) reported strong financial results for the last quarter, with EPS of 0.13 EUR, significantly exceeding the 0.06 EUR estimate. The company also surpassed revenue expectations, bringing in \u202a114.33 M\u202c EUR against an estimated \u202a112.44 M\u202c EUR. Analysts ", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-earnings/?earnings-period=FQ&revenues-period=FQ", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Dividends \u2013 LS:A2APNA", "summary": "The article provides a financial overview of Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It indicates that the market is currently closed with no trades, and offers information on the company's financials, including dividends, earnings, and revenue.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-dividends/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBITDA margin % of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article focuses on the EBITDA margin percentage of Bioventus, Inc. Class A, identified by the ticker LS:A2APNA on TradingView. It provides financial data for the company under the \"Markets\" section, specifically for German stocks in Health Technology and Medical Specialties.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/ebitda-margin/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CapEx per share of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the \"CapEx per share\" metric for Bioventus, Inc. Class A (LS:A2APNA). It appears to be a financial data page from TradingView, providing an overview of the company's capital expenditure per share. The content includes navigation elements common to a financi", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/capex-per-share/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Cash Flow \u2013 LS:A2APNA", "summary": "This article provides key financial data for Bioventus, Inc. Class A (LS:A2APNA), focusing on its cash flow activities. It highlights that the free cash flow for Q1 2026 was \u20ac7.24 million, and for the full year 2025, it was \u20ac60.80 million with an operating cash flow of \u20ac62.98 mil", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This page provides financial information for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It indicates that the market is currently closed without any trades. The page specifies that market and reference data are provided by ICE Data Services and FactSet, respectively.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/enterprise-value/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Revenue Breakdown \u2013 LS:A2APNA", "summary": "This article provides a revenue breakdown for Bioventus, Inc. Class A, trading under the symbol A2APNA on Lang & Schwarz Tradecenter. It highlights that the company generated 483.68 million EUR last year, with Pain Treatments being its highest-performing segment. The United State", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-revenue/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cost of goods sold of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the cost of goods sold for Bioventus, Inc. Class A (LS:A2APNA), providing financial data on this specific metric. It indicates that the information is \"Made by humans\" and sources market data from ICE Data Services and reference data from FactSet.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/cost-of-goods/", "source_name": "TradingView", "published_at": "2026-07-05T23:40:38", "published_display": "05 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pretax income of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the pretax income of Bioventus, Inc. Class A, identified by its stock symbol LS:A2APNA on the Lang & Schwarz Tradecenter. It indicates that the market is currently closed and no trades have occurred for this stock. The content appears to be a financial data", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/pretax-income/", "source_name": "TradingView", "published_at": "2026-07-05T22:39:39", "published_display": "05 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Revenue Breakdown \u2013 DUS:4B8", "summary": "Bioventus, Inc. Class A (DUS:4B8) generated 483.68 million EUR in revenue last year. The Pain Treatments segment was the top-performing segment, contributing 237.60 million EUR. The United States was the largest regional contributor, accounting for 427.49 million EUR.", "url": "https://www.tradingview.com/symbols/DUS-4B8/financials-revenue/", "source_name": "TradingView", "published_at": "2026-06-30T17:40:08", "published_display": "30 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Average basic shares outstanding of Bioventus, Inc. Class A \u2013 DUS:4B8", "summary": "This article provides financial data for Bioventus, Inc. Class A (DUS:4B8) on the Dusseldorf Stock Exchange. Specifically, it focuses on the \"Average basic shares outstanding\" for the company. The content appears to be a stub or a data point from a larger financial platform like ", "url": "https://www.tradingview.com/symbols/DUS-4B8/financials-income-statement/basic-shares-outstanding/", "source_name": "TradingView", "published_at": "2026-06-30T16:40:08", "published_display": "30 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Actuals & Estimates (NASDAQ:BVS)", "summary": "This article provides an overview of Bioventus Inc. (NASDAQ: BVS) stock, including its current price, historical performance, analyst forecasts, and financial data. It details the company's market capitalization, volatility, recent earnings, revenue figures, and upcoming earnings", "url": "https://www.tradingview.com/symbols/NASDAQ-BVS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:40:04", "published_display": "26 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bioventus, Inc. Class A \u2013 FWB:4B8", "summary": "The article provides information on the \"Price to earnings forward\" metric for Bioventus, Inc. Class A (FWB:4B8) on the Frankfurt Stock Exchange. It indicates no current trading activity with the market closed, and the specific value of the metric is listed as \"Period Value Chang", "url": "https://www.tradingview.com/symbols/FWB-4B8/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T07:11:30", "published_display": "26 Jun 2026 07:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bioventus, Inc. Class A \u2013 TRADEGATE:4B8", "summary": "This article displays the \"Price to earnings forward\" value for Bioventus, Inc. Class A (4B8) on the Tradegate Exchange. It indicates that the market is closed with no current trades. The data is provided by ICE Data Services and FactSet.", "url": "https://www.tradingview.com/symbols/TRADEGATE-4B8/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T06:11:12", "published_display": "26 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy Bioventus (BVS) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNekJYTl9hWlR1RGV5VWhvVi1vNlAySmpJbzBBR1ljcEN5VGJMXzJDQWZUTW1Xa0RfQjFMYUlKS1l6UTdMSUVaVGMta1Y0eVBrVUdyUzk1b3lNbGU2dHp3ejVwTlBQc29SSWh3b2t6RlowbDB6ZjVMclhmR0p3S0FiTWtELUh3TVk5cTducDNmWUkzaU1CaEt0anVQX3ljUWM?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Are Investors Undervaluing Bioventus (BVS) Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPR2t1N3NOa1VKMGdwSW5sVVF2LUptaWdpQm5PY2Q1LWRwSlNlX0pXUExYeEFKSVhsTjV3aXRNZ0dGNGQ1Q0ZQNGRzakotYmJpaFg0ZWg5cjZ3eDJEUkY3d0VoYUJoblFia1k3TjE0M0pyTHVMM1h1dU1iY3RDSGU1NmE1aWVYb2gwQ1JLNFN0SG9yMjU3TTl1NXNLM0VyaHZVQlN5RlVsTkc?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Edges Lower as Stock Tests Support Zone - Growth Factor", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxORjFZWXdGM0dOcFczMG1LOHhtV2hqREJDUGViSFNlTW84ZGQzcU1zM3JaMEVjMFplQzRjVnEyNkZPNExzdjlXWGN6N1ZHekdLV3RweUxZbjdGV0FYVlRfNXdBeXhRb3Fwem9xczhWRDVJT1BzZmNSd0Y1eEtYaWxtT0I5anpOWm1lc0dodHJaZkNPX2JJMmk0OFJNZXVJOGhUelZTWnBqemlBdGRN?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus Inc. (BVS) Gains 1.75% as Stock Tests Key Resistance Zone - ETH Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPLTZsRE1fVDdIdHRycEJnMXRqTmZ3dDZXVENGTGpVbTZBdFp3VDJqbFJLcW1Fa3NLT3d0dDhvbFFrSGo1dURQWVRZOUg3SWNrRnd3YWtwQTBxVTJUMWdaa2V1aWRNd2lWT1dKdEZRMVpaZGJJb1pFdHNfbHkzTjAtODgyd3F2MzJjWlhTUjNFaUhDZVJIUEZpSVdZbTdMeVBGZFhmTFVQNUU2dw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) director exercises RSUs and holds 148,892 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPaEs5Nk1GVVlOeG53cGVWUlBSZlJDNGctTVlhUjZvNmZvSkNCamM1MXRmTjJxZGZhbWw3eTMwRk1LeFdmSlYwbkwtaXhVTEMxRUs2dVFoVDJtdXBRSVFIQ1VHRGFvLWtpaUVHbURVWHZSYldBX3dCRFVwMjB4X0Y1Ny1ldlNlMmVDVGlObkV1cXFwS0tnNmhSZWEteG9wek9NSl9iWlFfZm1mUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOTVFWelVQNV9xbUJDWmc2MU5qdEQxdWtSaEpzckhZUHJCVk1fMTRpNFhyRi05SzNyejR4V3BicmZlbU9Sb2U0TkJidmdSZlJGZ0g2aHhkdjBVbkJwT0o1Q2FnX3dPRHdZVVdCbDFQQThicThVTG9WaXpQRm96bWJmc2NkZUxQaE1EckhuTHZOeDRCZmdT?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNOGtGR0EzSGVyT2pydVNEdDJUVTVIc3NPU1pzcTIza3lEaFF3dmpxem5UTFhzNkhyMEt1SC1WNVBxM2RUYlJWZzVzV1h1cVFaRURGT2JCZHZ1RTlJbVZfeEJsZE50a2Y5R0VvYzZiQzRWbVoyeUxHdUhGWkY1UkJMbXprUko0NVZ1YzhTVVA0NGhBWVdjOEhiUHhn?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bioventus (BVS) Stock Undervalued Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOR3dQdlA2bWxMZGtZWkIydnJCYUNrTXl2UUtOamYxSUVyRHkwemhzeG8wRnRlYjk0UjlJbjNxaEU0R2VZTVdjdVViRWRaREp2d1QtRzBUclR6YWdPYjBlWlZpYk5XZlpVY1RqMHpWYkxOSDAyb2dXbFZiMUZaamlZVjBEeW1iNU1jRF9kM3MxVzNiWk84U0tNTWszMWg1bHhTY2c?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Are Medical Stocks Lagging Bioventus (BVS) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNblFHOGxlZlBtczgzSkNqNy1hRUJ5RUdSM0pUbFpoZ2xhRmhyMDRLNlJQR3NWVmtXWVJkemU5MHpSc093aUNNSTFYaHU0UVdLZ3dsN0k0QnV4bHkzZ2syNGQwS3pEd1dKOFQtOVVneFJfOUhpdUliQ19XenRTLVMwcEoyUW1EbVdWeVFaTzZsQVJlMmlTRUE3TmxTeWJ6R1hxNVpB?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOdTEwNVgxcjBHSEFEMFA3UHVNb1pmUzJhWU10cE5Qd1RRaGkyTWlIOXhsZ1VvMHZnRzk0Smltd0Z3SGpYSGpjX2dLWDVISk15U1dsTzV4eGthUDVKRi1RUW1yaEd0RzVodXFuUFNrRlJXRXZScmVOY3hfYWp0OFY0RXZEY0hPY1FvWVo5RFdEQmRrYjhYdFhn?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Q1 EPS Holds Profitability But Tests Bullish Margin Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus Reports First Quarter Financial Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "Hillsdale Investment Management Inc. Raises Stake in Bioventus Inc. $BVS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPM1FNSWZyZkZxV2dsSzFqWGtXc3NOdHFZR21lLWhjbzBiRnI3UnlnU3VhcTRFX1JqSldFbFlWRTl0c1VxcjI1c1NEN3FWT0JzdHQ4RlZreF9XR0hJRlJlNDU4RXRFZ0R1RHBDeU55RU9Qeno1Q0Z0RGhQZDg5cWhCQjJLaG1jY1VYRU0xRVRjbFZuZzItNHFYQVlSb0hPYXUwOTRmT0NpUU81RW94aVVoRzd6WE5LYlNGa29SOVlpN09KbFM3d2hnelF3?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T10:35:49+00:00", "published_display": "15 Jul 2026 10:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus Inc. (NASDAQ:BVS) Given Average Rating of \"Buy\" by Brokerages", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZTZTNjh0Y2dCWlhxM1l2TmM0dlFWeVhseTQzZnM0MDRnUHhic2JoQWF0bzZGSEVJQVB5am5ZOTM5VWEtTjZrcmNMSU1vbnhpdHZFX0xXUXlfZ2p3Y0Q5ZE5JdHFJRzdaTkIyd1NaZkdRdk9zX1FtVUZkNF8tSU5neVNIZkpzTW1ic0JlR1VqaGJYbi05NWdDZEo3SERiVHg1NWVVcGlCblNiQ3JURFl2dVFTeWVOc3VhVDVv?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T08:20:57+00:00", "published_display": "15 Jul 2026 08:20", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Stock Looks Overvalued On Earnings Yet Backed By Broader Checks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxObWMzc1lKWkNMemFPTkVQeXBzV2RYUkxWZzZuVEVOUXhXSjFrcTB3UU11NTV4S2F5RkNBaUZEU1VGUUpQczZKYUxUMWZMeXd3akJBeUc1RFpRNXBuOXVQZVJSWnNBRk03cDJWN3VxV2xUbTA5b2x3NE9UcVV1bU41Q1V5eFRWUjdlRkNrMjhvVmc4SHphMXhiY01pSHFFQ214Tk5Z?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:14:10+00:00", "published_display": "10 Jul 2026 22:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Heads To An Investor Conference, Is It Still Below Fair Value?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T15:47:20+00:00", "published_display": "10 Jul 2026 15:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Actuals & Estimates (LSX:A2APNA)", "summary": "This article provides an overview of Bioventus, Inc. Class A (A2APNA) stock, including its current price, historical performance, and analyst forecasts. It also details financial actuals and estimates for income, balance sheet, and cash flow, along with information on earnings, r", "url": "https://www.tradingview.com/symbols/LSX-A2APNA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-07-10T03:40:15", "published_display": "10 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNRDNBTjl5WUcyaWVyTDRFMzhVeE5KOTBiTnZDb2d3Wk5WWmxuclMtUklXRXFZSktBQ0l1QjQyT1lKOGU1TTJ5WlppdzRydXQzY2o0QmN4dHpEaFNUdlJmT2hUWDBfUEJkNEZjMk1FWWVhT0RSWHd1TTVGbTE4NzNpYXBNVnZiUEhlRTB5TmE1aU1XN0pHdmF1am1B?oc=5", "source_name": "Market source", "published_at": "2026-07-08T16:00:03+00:00", "published_display": "08 Jul 2026 16:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQMzNjVHhoOFZQVEVjN1ZBWGhJR2pFREhmS0h2Tk1KeG9ONkVQdmxndmRyQ0xNZ2twQU10aGRRTlBlenE5UWEyTW5qVC00X1I3MjNUNmR1dW04QkdGaTVSRXJhOWpUZHZodG5na3RRVHRmNkJBenUxVTg4b3BzV2llWFN6Tm9hbUpIT0hzbndDa1UzUlpMNV9YTkZWTy0?oc=5", "source_name": "Market source", "published_at": "2026-07-08T13:55:01+00:00", "published_display": "08 Jul 2026 13:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A2APNA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an in-depth forecast for Bioventus, Inc. Class A (A2APNA) stock, including analyst price targets, past performance, and future earning estimates. It details current stock price, market capitalization, revenue, net income, and confirms that the company does n", "url": "https://www.tradingview.com/symbols/LSX-A2APNA/forecast/", "source_name": "TradingView", "published_at": "2026-07-08T12:40:15", "published_display": "08 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A2APNA Stock Price and Chart \u2014 LSX:A2APNA", "summary": "This article provides an overview of Bioventus, Inc. Class A (A2APNA) stock listed on the Lang & Schwarz Exchange, including key financial stats, upcoming earnings, and analyst insights. It details the company's business segments focusing on orthobiologics and musculoskeletal tre", "url": "https://www.tradingview.com/symbols/LSX-A2APNA/", "source_name": "TradingView", "published_at": "2026-07-07T18:13:46", "published_display": "07 Jul 2026 18:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zacks.com featured highlights include First Advantage, Bioventus and Ooma", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zacks-com-featured-highlights-first-081300491.html", "source_name": "Zacks", "published_at": "2026-07-07T08:13:00+00:00", "published_display": "07 Jul 2026 08:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQTW50MjNHZkd5Z19IMnJGMU1GTW1oTW5Xd19BRzB4Z2FZdzdjYVZLRzdGMkJhWWlyZlFUZFNOaU9zcEgzcXRHNGhqeS1XY3FpRFRNcHd4b0FUR09tWVRnZTBMMzhaamNYbmNJd3RJOEFybG5wNzJjSHotcmRRUkJsbDR3XzA5SjN2enFmdU9WMHlFWVU?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Debt to assets ratio of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article provides financial information for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It specifically highlights the debt to assets ratio for the company. The content also mentions the data sources and copyright information.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/debt-to-asset/", "source_name": "TradingView", "published_at": "2026-07-07T00:13:46", "published_display": "07 Jul 2026 00:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash flow from financing activities of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides financial data specifically on the cash flow from financing activities of Bioventus, Inc. Class A, traded under the symbol LS:A2APNA. The content is presented within the TradingView platform, noting the market status as closed with no trades. It highlights t", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-cash-flow/cash-f-financing-activities/", "source_name": "TradingView", "published_at": "2026-07-07T00:13:46", "published_display": "07 Jul 2026 00:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash per share of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides financial information for Bioventus, Inc. Class A (LS:A2APNA), specifically focusing on its cash per share. It appears to be a financial data page from TradingView, including general market information and links to various financial tools and community featu", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/cash-per-share/", "source_name": "TradingView", "published_at": "2026-07-06T13:39:33", "published_display": "06 Jul 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Return on equity % of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article provides a financial overview of Bioventus, Inc. Class A (A2APNA) on TradingView, specifically focusing on its Return on Equity (ROE) percentage. It indicates that the market was closed at the time of access and no trades were recorded. The content is part of a larger", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/return-on-equity/", "source_name": "TradingView", "published_at": "2026-07-06T13:09:41", "published_display": "06 Jul 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total revenue of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides financial information for Bioventus, Inc. Class A under the ticker LS:A2APNA on TradingView. It specifically highlights the \"Total revenue\" section within the financial data for the company. The content appears to be a stub or a section of a larger financial", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/total-revenue/", "source_name": "TradingView", "published_at": "2026-07-06T12:40:15", "published_display": "06 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBITDA of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article displays the EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It provides financial data for the company, indicating the period, value, and percentage change. The article focuses solely o", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/ebitda/", "source_name": "TradingView", "published_at": "2026-07-06T12:10:44", "published_display": "06 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Statistics \u2013 LS:A2APNA", "summary": "This page provides financial statistics and ratios for Bioventus, Inc. Class A (LS:A2APNA) on the Lang & Schwarz Tradecenter, including valuation, profitability, liquidity, solvency ratios, and per-share metrics. Users can access annual or quarterly data going back to 2013, thoug", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/", "source_name": "TradingView", "published_at": "2026-07-06T12:10:44", "published_display": "06 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash flow from investing activities of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article displays the cash flow from investing activities for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It appears to be a financial data page rather than a traditional article, providing access to financial information without detailed textual analysis. The content", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-cash-flow/cash-f-investing-activities/", "source_name": "TradingView", "published_at": "2026-07-06T12:10:44", "published_display": "06 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Income Statement \u2013 LS:A2APNA", "summary": "This article presents the income statement for Bioventus, Inc. Class A (A2APNA), indicating the total revenue for the last quarter was 114.33 million EUR, a 14.96% decrease from the previous quarter. The net income for Q1 2026 was 2.69 million EUR. The report includes an overview", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/", "source_name": "TradingView", "published_at": "2026-07-06T10:40:38", "published_display": "06 Jul 2026 10:40", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Equity in earnings of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article provides details on the equity in earnings for Bioventus, Inc. Class A (LS:A2APNA), as listed on the Lang & Schwarz Tradecenter. It indicates that the market is currently closed with no trades recorded. The page includes general market and financial data overview, wi", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/equity-in-earnings/", "source_name": "TradingView", "published_at": "2026-07-06T03:40:38", "published_display": "06 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the \"Price to sales forward\" metric for Bioventus, Inc. Class A, traded under the symbol A2APNA on the Lang & Schwarz Tradecenter. It provides an overview of the financial data available for this company through TradingView, noting that the market was close", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T01:10:32", "published_display": "06 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This page from TradingView provides financial information for Bioventus, Inc. Class A (LS:A2APNA), specifically focusing on its forward price-to-earnings ratio. The content indicates that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. It i", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T00:41:00", "published_display": "06 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Earnings and Revenue \u2013 LS:A2APNA", "summary": "Bioventus, Inc. Class A (A2APNA) reported strong financial results for the last quarter, with EPS of 0.13 EUR, significantly exceeding the 0.06 EUR estimate. The company also surpassed revenue expectations, bringing in \u202a114.33 M\u202c EUR against an estimated \u202a112.44 M\u202c EUR. Analysts ", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-earnings/?earnings-period=FQ&revenues-period=FQ", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Dividends \u2013 LS:A2APNA", "summary": "The article provides a financial overview of Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It indicates that the market is currently closed with no trades, and offers information on the company's financials, including dividends, earnings, and revenue.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-dividends/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBITDA margin % of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This article focuses on the EBITDA margin percentage of Bioventus, Inc. Class A, identified by the ticker LS:A2APNA on TradingView. It provides financial data for the company under the \"Markets\" section, specifically for German stocks in Health Technology and Medical Specialties.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/ebitda-margin/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CapEx per share of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the \"CapEx per share\" metric for Bioventus, Inc. Class A (LS:A2APNA). It appears to be a financial data page from TradingView, providing an overview of the company's capital expenditure per share. The content includes navigation elements common to a financi", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/capex-per-share/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Cash Flow \u2013 LS:A2APNA", "summary": "This article provides key financial data for Bioventus, Inc. Class A (LS:A2APNA), focusing on its cash flow activities. It highlights that the free cash flow for Q1 2026 was \u20ac7.24 million, and for the full year 2025, it was \u20ac60.80 million with an operating cash flow of \u20ac62.98 mil", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "This page provides financial information for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It indicates that the market is currently closed without any trades. The page specifies that market and reference data are provided by ICE Data Services and FactSet, respectively.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-statistics-and-ratios/enterprise-value/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Revenue Breakdown \u2013 LS:A2APNA", "summary": "This article provides a revenue breakdown for Bioventus, Inc. Class A, trading under the symbol A2APNA on Lang & Schwarz Tradecenter. It highlights that the company generated 483.68 million EUR last year, with Pain Treatments being its highest-performing segment. The United State", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-revenue/", "source_name": "TradingView", "published_at": "2026-07-06T00:40:38", "published_display": "06 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cost of goods sold of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the cost of goods sold for Bioventus, Inc. Class A (LS:A2APNA), providing financial data on this specific metric. It indicates that the information is \"Made by humans\" and sources market data from ICE Data Services and reference data from FactSet.", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/cost-of-goods/", "source_name": "TradingView", "published_at": "2026-07-05T23:40:38", "published_display": "05 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pretax income of Bioventus, Inc. Class A \u2013 LS:A2APNA", "summary": "The article focuses on the pretax income of Bioventus, Inc. Class A, identified by its stock symbol LS:A2APNA on the Lang & Schwarz Tradecenter. It indicates that the market is currently closed and no trades have occurred for this stock. The content appears to be a financial data", "url": "https://www.tradingview.com/symbols/LS-A2APNA/financials-income-statement/pretax-income/", "source_name": "TradingView", "published_at": "2026-07-05T22:39:39", "published_display": "05 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Revenue Breakdown \u2013 DUS:4B8", "summary": "Bioventus, Inc. Class A (DUS:4B8) generated 483.68 million EUR in revenue last year. The Pain Treatments segment was the top-performing segment, contributing 237.60 million EUR. The United States was the largest regional contributor, accounting for 427.49 million EUR.", "url": "https://www.tradingview.com/symbols/DUS-4B8/financials-revenue/", "source_name": "TradingView", "published_at": "2026-06-30T17:40:08", "published_display": "30 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Average basic shares outstanding of Bioventus, Inc. Class A \u2013 DUS:4B8", "summary": "This article provides financial data for Bioventus, Inc. Class A (DUS:4B8) on the Dusseldorf Stock Exchange. Specifically, it focuses on the \"Average basic shares outstanding\" for the company. The content appears to be a stub or a data point from a larger financial platform like ", "url": "https://www.tradingview.com/symbols/DUS-4B8/financials-income-statement/basic-shares-outstanding/", "source_name": "TradingView", "published_at": "2026-06-30T16:40:08", "published_display": "30 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus, Inc. Class A Actuals & Estimates (NASDAQ:BVS)", "summary": "This article provides an overview of Bioventus Inc. (NASDAQ: BVS) stock, including its current price, historical performance, analyst forecasts, and financial data. It details the company's market capitalization, volatility, recent earnings, revenue figures, and upcoming earnings", "url": "https://www.tradingview.com/symbols/NASDAQ-BVS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:40:04", "published_display": "26 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bioventus, Inc. Class A \u2013 FWB:4B8", "summary": "The article provides information on the \"Price to earnings forward\" metric for Bioventus, Inc. Class A (FWB:4B8) on the Frankfurt Stock Exchange. It indicates no current trading activity with the market closed, and the specific value of the metric is listed as \"Period Value Chang", "url": "https://www.tradingview.com/symbols/FWB-4B8/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T07:11:30", "published_display": "26 Jun 2026 07:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Bioventus, Inc. Class A \u2013 TRADEGATE:4B8", "summary": "This article displays the \"Price to earnings forward\" value for Bioventus, Inc. Class A (4B8) on the Tradegate Exchange. It indicates that the market is closed with no current trades. The data is provided by ICE Data Services and FactSet.", "url": "https://www.tradingview.com/symbols/TRADEGATE-4B8/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T06:11:12", "published_display": "26 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy Bioventus (BVS) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNekJYTl9hWlR1RGV5VWhvVi1vNlAySmpJbzBBR1ljcEN5VGJMXzJDQWZUTW1Xa0RfQjFMYUlKS1l6UTdMSUVaVGMta1Y0eVBrVUdyUzk1b3lNbGU2dHp3ejVwTlBQc29SSWh3b2t6RlowbDB6ZjVMclhmR0p3S0FiTWtELUh3TVk5cTducDNmWUkzaU1CaEt0anVQX3ljUWM?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Investors Undervaluing Bioventus (BVS) Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPR2t1N3NOa1VKMGdwSW5sVVF2LUptaWdpQm5PY2Q1LWRwSlNlX0pXUExYeEFKSVhsTjV3aXRNZ0dGNGQ1Q0ZQNGRzakotYmJpaFg0ZWg5cjZ3eDJEUkY3d0VoYUJoblFia1k3TjE0M0pyTHVMM1h1dU1iY3RDSGU1NmE1aWVYb2gwQ1JLNFN0SG9yMjU3TTl1NXNLM0VyaHZVQlN5RlVsTkc?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Edges Lower as Stock Tests Support Zone - Growth Factor", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxORjFZWXdGM0dOcFczMG1LOHhtV2hqREJDUGViSFNlTW84ZGQzcU1zM3JaMEVjMFplQzRjVnEyNkZPNExzdjlXWGN6N1ZHekdLV3RweUxZbjdGV0FYVlRfNXdBeXhRb3Fwem9xczhWRDVJT1BzZmNSd0Y1eEtYaWxtT0I5anpOWm1lc0dodHJaZkNPX2JJMmk0OFJNZXVJOGhUelZTWnBqemlBdGRN?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus Inc. (BVS) Gains 1.75% as Stock Tests Key Resistance Zone - ETH Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPLTZsRE1fVDdIdHRycEJnMXRqTmZ3dDZXVENGTGpVbTZBdFp3VDJqbFJLcW1Fa3NLT3d0dDhvbFFrSGo1dURQWVRZOUg3SWNrRnd3YWtwQTBxVTJUMWdaa2V1aWRNd2lWT1dKdEZRMVpaZGJJb1pFdHNfbHkzTjAtODgyd3F2MzJjWlhTUjNFaUhDZVJIUEZpSVdZbTdMeVBGZFhmTFVQNUU2dw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) director exercises RSUs and holds 148,892 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPaEs5Nk1GVVlOeG53cGVWUlBSZlJDNGctTVlhUjZvNmZvSkNCamM1MXRmTjJxZGZhbWw3eTMwRk1LeFdmSlYwbkwtaXhVTEMxRUs2dVFoVDJtdXBRSVFIQ1VHRGFvLWtpaUVHbURVWHZSYldBX3dCRFVwMjB4X0Y1Ny1ldlNlMmVDVGlObkV1cXFwS0tnNmhSZWEteG9wek9NSl9iWlFfZm1mUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOTVFWelVQNV9xbUJDWmc2MU5qdEQxdWtSaEpzckhZUHJCVk1fMTRpNFhyRi05SzNyejR4V3BicmZlbU9Sb2U0TkJidmdSZlJGZ0g2aHhkdjBVbkJwT0o1Q2FnX3dPRHdZVVdCbDFQQThicThVTG9WaXpQRm96bWJmc2NkZUxQaE1EckhuTHZOeDRCZmdT?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNOGtGR0EzSGVyT2pydVNEdDJUVTVIc3NPU1pzcTIza3lEaFF3dmpxem5UTFhzNkhyMEt1SC1WNVBxM2RUYlJWZzVzV1h1cVFaRURGT2JCZHZ1RTlJbVZfeEJsZE50a2Y5R0VvYzZiQzRWbVoyeUxHdUhGWkY1UkJMbXprUko0NVZ1YzhTVVA0NGhBWVdjOEhiUHhn?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bioventus (BVS) Stock Undervalued Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOR3dQdlA2bWxMZGtZWkIydnJCYUNrTXl2UUtOamYxSUVyRHkwemhzeG8wRnRlYjk0UjlJbjNxaEU0R2VZTVdjdVViRWRaREp2d1QtRzBUclR6YWdPYjBlWlZpYk5XZlpVY1RqMHpWYkxOSDAyb2dXbFZiMUZaamlZVjBEeW1iNU1jRF9kM3MxVzNiWk84U0tNTWszMWg1bHhTY2c?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Bioventus (BVS) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNblFHOGxlZlBtczgzSkNqNy1hRUJ5RUdSM0pUbFpoZ2xhRmhyMDRLNlJQR3NWVmtXWVJkemU5MHpSc093aUNNSTFYaHU0UVdLZ3dsN0k0QnV4bHkzZ2syNGQwS3pEd1dKOFQtOVVneFJfOUhpdUliQ19XenRTLVMwcEoyUW1EbVdWeVFaTzZsQVJlMmlTRUE3TmxTeWJ6R1hxNVpB?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOdTEwNVgxcjBHSEFEMFA3UHVNb1pmUzJhWU10cE5Qd1RRaGkyTWlIOXhsZ1VvMHZnRzk0Smltd0Z3SGpYSGpjX2dLWDVISk15U1dsTzV4eGthUDVKRi1RUW1yaEd0RzVodXFuUFNrRlJXRXZScmVOY3hfYWp0OFY0RXZEY0hPY1FvWVo5RFdEQmRrYjhYdFhn?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus (BVS) Q1 EPS Holds Profitability But Tests Bullish Margin Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bioventus Reports First Quarter Financial Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 101, "total_relevant": 67, "sentiment_summary": {"positive": 13, "negative": 2, "neutral": 52, "score": 53, "total": 67, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 14.99, "count": 30}, {"event": "general", "label": "Market update", "weight": 14.65, "count": 26}, {"event": "liquidity", "label": "Balance sheet", "weight": 3.3, "count": 6}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 13, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 11.88, "latest_week": "2026-07-10", "one_week_move": 13.4, "four_week_move": 39.6, "twelve_week_move": 12.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.01462, "market_dynamics_buy_signal": false, "relative_strength": 25.920597, "fair_value_gap": 60.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.6108, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+13.4% over one week, +39.6% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 29}, {"label": "Market source", "count": 20}, {"label": "MarketBeat", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "Zacks", "count": 1}, {"label": "B\u00f6l\u00fcm Sonu Canavar\u0131", "count": 1}, {"label": "dars.gov.et", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 56}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 30}, {"label": "Market update", "count": 26}, {"label": "Balance sheet", "count": 6}, {"label": "Analyst action", "count": 3}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "56", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+13.4% over one week, +39.6% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Hillsdale Investment Management Inc. Raises Stake in Bioventus Inc. $BVS"}], "updated_at": "2026-07-16T01:33:53.271165+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}